| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5699314 | Clinical Oncology | 2010 | 6 Pages |
Abstract
This is the largest reported series from the UK focussing on patients who received CRT for pancreas cancer. It shows that it is possible to deliver pancreatic CRT with acceptable toxicity. Induction chemotherapy followed by gemcitabine-based CRT shows promising activity and should be evaluated in phase III studies.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
R. Gillmore, V. Laurence, S. Raouf, J. Tobias, G. Blackman, T. Meyer, K. Goodchild, C. Collis, J. Bridgewater,